Health
Drug May Reduce Tumor Volume in Neurofibromatosis – Technology Networks
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
Noosa News19 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News21 hours agoR Tee in the running to be top dog
-
Noosa News19 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business18 hours ago3 steps to take to build a $1,000 monthly passive income